Market-first feature leverages mobile and sensor technology via PAREXEL’s ClinPhonereg; RTSM mobile app to prevent temperature-compromised medication from reaching clinical trial patientsBOSTON, October 27, 2017 – PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced a new feature for its ClinPhonereg; RTSM (randomization and trial supply management) Mobile App that addresses the workflow and safety issues commonly associated with the packaging, transport, and storage of temperature-sensitive medications.

The industry-first capability will provide end-to-end…

Source: RealWire

Leave a Reply